Guizhou Yibai Pharmaceutical Co., Ltd. (GUIZHOU YIBAI PHARMACEUTICAL CO) Aktie
600594.SS
GeschlossenGUIZHOU YIBAI PHARMACEUTICAL CO
Market Cap
$2,732,149,760
Über Guizhou Yibai Pharmaceutical Co., Ltd. (GUIZHOU YIBAI PHARMACEUTICAL CO) Aktie
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials. In addition, it is involved in the research and development, and information consulting services for health food. The company was founded in 1995 and is based in Guiyang, China.
Unternehmensinformationen
550008 Guiyang, China
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.